Variant report
Variant | nsv879491 |
---|---|
Chromosome Location | chr4:74275515-74292407 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:274)
- CpG islands (count:489)
- Chromatin interactive region (count:4)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr4:74287019-74289137 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr4:74275185-74275541 | HepG2 | liver: | n/a | n/a |
3 | ARID3A | chr4:74281297-74281307 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr4:74281539-74282715 | HepG2 | liver: | n/a | n/a |
5 | ARID3A | chr4:74277177-74277971 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr4:74281593-74281901 | HepG2 | liver: | n/a | chr4:74281704-74281715 |
7 | CEBPB | chr4:74281516-74282016 | HepG2 | liver: | n/a | chr4:74281704-74281715 |
8 | CEBPB | chr4:74288735-74289068 | HepG2 | liver: | n/a | chr4:74288884-74288897 chr4:74288901-74288912 chr4:74288900-74288913 chr4:74288900-74288913 |
9 | CEBPB | chr4:74284445-74284766 | HepG2 | liver: | n/a | chr4:74284600-74284613 chr4:74284602-74284613 chr4:74284524-74284537 chr4:74284600-74284613 chr4:74284602-74284613 chr4:74284600-74284611 |
10 | CEBPB | chr4:74281549-74281983 | HepG2 | liver: | n/a | chr4:74281704-74281715 |
11 | CEBPB | chr4:74275337-74275531 | HepG2 | liver: | n/a | chr4:74275438-74275451 |
12 | CEBPB | chr4:74281692-74281851 | K562 | blood: | n/a | chr4:74281704-74281715 |
13 | CEBPB | chr4:74281642-74281919 | H1-hESC | embryonic stem cell: | n/a | chr4:74281704-74281715 |
14 | CEBPB | chr4:74281532-74281913 | HepG2 | liver: | n/a | chr4:74281704-74281715 |
15 | CEBPB | chr4:74281664-74281800 | IMR90 | lung: | n/a | chr4:74281704-74281715 |
16 | CEBPD | chr4:74287882-74288232 | HepG2 | liver: | n/a | n/a |
17 | CEBPD | chr4:74287611-74287839 | HepG2 | liver: | n/a | n/a |
18 | CEBPD | chr4:74281549-74281954 | HepG2 | liver: | n/a | n/a |
19 | CREB1 | chr4:74287275-74287894 | HepG2 | liver: | n/a | n/a |
20 | CTCF | chr4:74283513-74283610 | GM10266 | blood: | n/a | n/a |
21 | ELF1 | chr4:74287915-74288250 | HepG2 | liver: | n/a | n/a |
22 | EP300 | chr4:74281438-74282102 | HepG2 | liver: | n/a | n/a |
23 | EP300 | chr4:74281523-74281953 | HepG2 | liver: | n/a | n/a |
24 | FOS | chr4:74281660-74281787 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOSL2 | chr4:74287229-74288366 | HepG2 | liver: | n/a | n/a |
26 | FOXA1 | chr4:74287509-74287947 | HepG2 | liver: | n/a | n/a |
27 | FOXA1 | chr4:74287377-74288234 | HepG2 | liver: | n/a | n/a |
28 | FOXA1 | chr4:74287345-74287933 | HepG2 | liver: | n/a | n/a |
29 | FOXA1 | chr4:74281501-74282026 | HepG2 | liver: | n/a | n/a |
30 | FOXA1 | chr4:74287274-74288464 | HepG2 | liver: | n/a | n/a |
31 | FOXA1 | chr4:74286294-74286758 | HepG2 | liver: | n/a | n/a |
32 | FOXA1 | chr4:74292340-74292768 | HepG2 | liver: | n/a | n/a |
33 | FOXA1 | chr4:74281532-74281999 | HepG2 | liver: | n/a | n/a |
34 | FOXA1 | chr4:74281602-74281911 | HepG2 | liver: | n/a | n/a |
35 | FOXA2 | chr4:74287443-74287939 | HepG2 | liver: | n/a | n/a |
36 | FOXA2 | chr4:74281570-74281969 | HepG2 | liver: | n/a | n/a |
37 | FOXA2 | chr4:74292382-74292703 | HepG2 | liver: | n/a | n/a |
38 | FOXA2 | chr4:74286235-74286709 | HepG2 | liver: | n/a | n/a |
39 | FOXA2 | chr4:74275282-74275605 | HepG2 | liver: | n/a | n/a |
40 | FOXA2 | chr4:74282227-74282450 | HepG2 | liver: | n/a | n/a |
41 | GATA3 | chr4:74281388-74281673 | SH-SY5Y | brain: | n/a | n/a |
42 | HCFC1 | chr4:74283742-74283953 | K562 | blood: | n/a | n/a |
43 | HDAC2 | chr4:74281555-74281928 | HepG2 | liver: | n/a | chr4:74281875-74281889 |
44 | HDAC2 | chr4:74281583-74281966 | HepG2 | liver: | n/a | chr4:74281875-74281889 |
45 | HEY1 | chr4:74280386-74281034 | HepG2 | liver: | n/a | n/a |
46 | HEY1 | chr4:74284287-74284791 | HepG2 | liver: | n/a | n/a |
47 | HEY1 | chr4:74278363-74278611 | HepG2 | liver: | n/a | n/a |
48 | HEY1 | chr4:74281153-74283631 | HepG2 | liver: | n/a | n/a |
49 | HEY1 | chr4:74285707-74286142 | HepG2 | liver: | n/a | n/a |
50 | HEY1 | chr4:74288598-74288826 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:74276031-74276081 | MCF-7 | breast: | n/a |
2 | chr4:74276031-74276081 | MCF-7 | breast: | n/a |
3 | chr4:74279174-74279224 | HCF | heart: | n/a |
4 | chr4:74277799-74277849 | GM12892 | blood: | n/a |
5 | chr4:74276031-74276081 | HEEpiC | esophagus: | n/a |
6 | chr4:74277799-74277849 | ovcar-3 | ovarian: | n/a |
7 | chr4:74280794-74280844 | ProgFib | skin: | n/a |
8 | chr4:74280794-74280844 | AG10803 | skin: | n/a |
9 | chr4:74279138-74279188 | Hela-S3 | cervix: | n/a |
10 | chr4:74280794-74280844 | SK-N-MC | brain: | n/a |
11 | chr4:74279138-74279188 | AG09319 | gingival: | n/a |
12 | chr4:74285329-74285379 | U87 | brain: | n/a |
13 | chr4:74277799-74277849 | U87 | brain: | n/a |
14 | chr4:74277799-74277849 | Hepatocyte | liver: | n/a |
15 | chr4:74279174-74279224 | RPTEC | kidney: | n/a |
16 | chr4:74277723-74277773 | HRE | kidney: | n/a |
17 | chr4:74277799-74277849 | HCF | heart: | n/a |
18 | chr4:74286665-74286715 | BE2_C | brain: | n/a |
19 | chr4:74279138-74279188 | HCPEpiC | choroid plexus: | n/a |
20 | chr4:74280794-74280844 | ovcar-3 | ovarian: | n/a |
21 | chr4:74276031-74276081 | HCM | heart: | n/a |
22 | chr4:74279138-74279188 | NT2-D1 | testis: | n/a |
23 | chr4:74285329-74285379 | BE2_C | brain: | n/a |
24 | chr4:74277799-74277849 | LNCaP | prostate: | n/a |
25 | chr4:74276031-74276081 | PrEC | prostate: | n/a |
26 | chr4:74286665-74286715 | PFSK-1 | brain: | n/a |
27 | chr4:74279174-74279224 | AoSMC | blood vessel: | n/a |
28 | chr4:74276031-74276081 | HUVEC | blood vessel: | n/a |
29 | chr4:74277799-74277849 | MCF-7 | breast: | n/a |
30 | chr4:74276031-74276081 | HRCEpiC | kidney: | n/a |
31 | chr4:74285329-74285379 | AG04450 | lung: | fetal |
32 | chr4:74276031-74276081 | LNCaP | prostate: | n/a |
33 | chr4:74276031-74276081 | Hepatocyte | liver: | n/a |
34 | chr4:74286665-74286715 | HL-60 | blood: | n/a |
35 | chr4:74279138-74279188 | ProgFib | skin: | n/a |
36 | chr4:74277723-74277773 | AG04450 | lung: | fetal |
37 | chr4:74286665-74286715 | RPTEC | kidney: | n/a |
38 | chr4:74276031-74276081 | HL-60 | blood: | n/a |
39 | chr4:74277723-74277773 | AoSMC | blood vessel: | n/a |
40 | chr4:74279138-74279188 | HNPCEpiC | eye: | n/a |
41 | chr4:74280794-74280844 | AG09309 | skin: | n/a |
42 | chr4:74286665-74286715 | AoSMC | blood vessel: | n/a |
43 | chr4:74277799-74277849 | AG09319 | gingival: | n/a |
44 | chr4:74285329-74285379 | PANC-1 | pancreas: | n/a |
45 | chr4:74279174-74279224 | HEK293 | kidney: | embryo |
46 | chr4:74280794-74280844 | SKMC | muscle: | n/a |
47 | chr4:74279174-74279224 | SK-N-SH_RA | brain: | n/a |
48 | chr4:74277799-74277849 | GM12891 | blood: | n/a |
49 | chr4:74277723-74277773 | Hela-S3 | cervix: | n/a |
50 | chr4:74277723-74277773 | NT2-D1 | testis: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:74276363..74279027-chr4:74289491..74291603,2 | K562 | blood: | |
2 | chr4:74289653..74292919-chr4:74294255..74297611,3 | K562 | blood: | |
3 | chr4:74276426..74278467-chr4:74310127..74311716,2 | K562 | blood: | |
4 | chr4:74281238..74283827-chr4:74315947..74318394,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AFP-1 | chr4:74284998-74285172 | NONHSAT096847 |
2 | lnc-AFP-1 | chr4:74285971-74286038 | NONHSAT096847 |
3 | lnc-AFP-1 | chr4:74286809-74286934 | NONHSAT096847 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ALB | TF binding region |
AFP | TF binding region |
ALB | CpG island |
AFP | CpG island |
ENSG00000081051 | chromatin interactions |
ENSG00000163631 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3775486 | chr4:74275515-74275516 | Transcr. at gene 5' and 3' Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs200102919 | chr4:74275604-74275605 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs371191077 | chr4:74275623-74275624 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs183247535 | chr4:74275659-74275660 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs142769563 | chr4:74275670-74275671 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs537483955 | chr4:74275685-74275686 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs147371475 | chr4:74275745-74275746 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs188705172 | chr4:74275792-74275793 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs575683754 | chr4:74275803-74275804 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs3775485 | chr4:74275821-74275822 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs553612082 | chr4:74275832-74275833 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs578234675 | chr4:74275897-74275898 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs545268057 | chr4:74275952-74275953 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs564036666 | chr4:74275954-74275955 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs370718057 | chr4:74275977-74275978 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs531095851 | chr4:74276024-74276025 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs61375018 | chr4:74276026-74276027 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs560693428 | chr4:74276031-74276032 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs146587652 | chr4:74276034-74276035 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs267600248 | chr4:74276041-74276042 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs58624704 | chr4:74276042-74276043 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs11538220 | chr4:74276053-74276054 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs17400586 | chr4:74276055-74276056 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs3210154 | chr4:74276056-74276057 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs3204504 | chr4:74276057-74276058 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs140065129 | chr4:74276061-74276062 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs11538228 | chr4:74276066-74276067 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs3210163 | chr4:74276072-74276073 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs373929336 | chr4:74276088-74276089 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs377345537 | chr4:74276113-74276114 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs74899956 | chr4:74276128-74276129 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs370277478 | chr4:74276144-74276145 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs55772354 | chr4:74276150-74276151 | Transcr. at gene 5' and 3' Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs546249391 | chr4:74276209-74276210 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs571002394 | chr4:74276238-74276239 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs191154489 | chr4:74276265-74276266 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs34052046 | chr4:74276289-74276290 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs550481981 | chr4:74276327-74276328 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs56285841 | chr4:74276524-74276525 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs56343254 | chr4:74276564-74276565 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs528152032 | chr4:74276566-74276567 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs555732819 | chr4:74276621-74276622 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs573307826 | chr4:74276622-74276623 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs142102638 | chr4:74276625-74276626 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs140039805 | chr4:74276672-74276673 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs535004379 | chr4:74276762-74276763 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs574006628 | chr4:74276765-74276766 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs201391882 | chr4:74276768-74276769 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs553549083 | chr4:74276771-74276772 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs111923618 | chr4:74276772-74276773 | Transcr. at gene 5' and 3' Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:74271600-74283200 | Transcr. at gene 5' and 3' | HepG2 | liver |
2 | chr4:74272000-74283400 | Transcr. at gene 5' and 3' | Liver | Liver |
3 | chr4:74272000-74298200 | Weak transcription | Pancreas | Pancrea |
4 | chr4:74274000-74276000 | Enhancers | Fetal Intestine Small | intestine |
5 | chr4:74274400-74275600 | Weak transcription | Fetal Intestine Large | intestine |
6 | chr4:74275600-74276200 | Enhancers | Fetal Intestine Large | intestine |
7 | chr4:74280400-74286400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr4:74281600-74282000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr4:74283200-74283600 | Active TSS | HepG2 | liver |
10 | chr4:74283400-74287400 | Strong transcription | Liver | Liver |
11 | chr4:74283600-74284200 | Transcr. at gene 5' and 3' | HepG2 | liver |
12 | chr4:74284200-74284400 | Genic enhancers | HepG2 | liver |
13 | chr4:74284400-74287000 | Strong transcription | HepG2 | liver |
14 | chr4:74285000-74285200 | Enhancers | Brain Inferior Temporal Lobe | brain |
15 | chr4:74285000-74285400 | Enhancers | Brain Hippocampus Middle | brain |
16 | chr4:74285000-74285600 | Enhancers | Brain Cingulate Gyrus | brain |
17 | chr4:74285200-74285400 | Enhancers | Brain Angular Gyrus | brain |
18 | chr4:74285200-74285600 | Active TSS | Brain Inferior Temporal Lobe | brain |
19 | chr4:74285400-74286400 | Weak transcription | Brain Hippocampus Middle | brain |
20 | chr4:74285600-74286000 | Weak transcription | Brain Cingulate Gyrus | brain |
21 | chr4:74285600-74286600 | Enhancers | Brain Inferior Temporal Lobe | brain |
22 | chr4:74286200-74286400 | Enhancers | Brain Cingulate Gyrus | brain |
23 | chr4:74286200-74286800 | Enhancers | Brain Substantia Nigra | brain |
24 | chr4:74286400-74286600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
25 | chr4:74286400-74286800 | Enhancers | Brain Hippocampus Middle | brain |
26 | chr4:74287000-74291200 | Weak transcription | HepG2 | liver |
27 | chr4:74287400-74295400 | Weak transcription | Liver | Liver |
28 | chr4:74291200-74297000 | Enhancers | HepG2 | liver |